Freestone Grove Partners »

Caris Life Sciences shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.6M 251k 30.25
2025-06-30 $1.3M 50k 26.72

More positions owned by Freestone Grove Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Weyerhaeuser Co Mtn Be Com New (WY)
Cintas Corporation (CTAS)
MasTec (MTZ)
Microsoft Corporation (MSFT)
EOG Resources (EOG)
KB Home (KBH)
First Horizon National Corporation (FHN)
Netflix (NFLX)
Procter & Gamble Company (PG)
At&t (T)
Twilio Cl A (TWLO)
3M Company (MMM)
Vulcan Materials Company (VMC)

View all positions for Freestone Grove Partners

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
Silver Lake Group
Neuberger Berman Group
Millennium Management
PointState Capital
OrbiMed Advisors
Ameriprise Financial
ClearBridge Advisors
Canada Pension Plan Investment Board
Alliancebernstein
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences